17 (7%) patients had a mild hepatic comorbidity (score 1) (bilirubin > ULN to 1.5 × ULN or AST/ALT > ULN to 2.5 × ULN) and 1 patient additional liver cirrhosis with portal hypertension (score 3). This evidence concerns the gene GPT and liver disorder.